The epidemiology of carbapenemases in Latin America and the Caribbean
K Escandón-Vargas, S Reyes, S Gutiérrez… - Expert review of anti …, 2017 - Taylor & Francis
ABSTRACT Introduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp.
infections are major causes of morbidity and mortality, especially due to the emergence and …
infections are major causes of morbidity and mortality, especially due to the emergence and …
Update on the epidemiology of carbapenemases in Latin America and the Caribbean
Introduction Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam
antibiotics, including carbapenems. Carbapenemase production in Enterobacterales …
antibiotics, including carbapenems. Carbapenemase production in Enterobacterales …
Prevalence of VIM- and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection
SAS Girija, VP Jayaseelan… - Acta microbiologica et …, 2018 - akjournals.com
Carbapenems are administered as the final drug of choice for treating complicated
nosocomial infections caused by multidrug-resistant Acinetobacter baumannii strains. It is …
nosocomial infections caused by multidrug-resistant Acinetobacter baumannii strains. It is …
Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years
Colistin resistance involving Gram-negative bacilli infections is a challenge for health
institutions around of the world. Carbapenem-resistance among these isolates makes …
institutions around of the world. Carbapenem-resistance among these isolates makes …
Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center
KCF de Almeida, MA Calomino, G Deutsch… - Burns, 2017 - Elsevier
Objective The aim of this study was to characterize molecularly multidrug-resistant (MDR)
Pseudomonas aeruginosa isolates collected from burn center (BC) patients and …
Pseudomonas aeruginosa isolates collected from burn center (BC) patients and …
Prevalence and characterization of carbapenem‐resistant bacteria in water bodies in the Los Angeles–Southern California area
DE Harmon, OA Miranda, A McCarley… - …, 2019 - Wiley Online Library
Carbapenems are β‐lactam antibiotics used in healthcare settings as last resort drugs to
treat infections caused by antibiotic‐resistant bacteria. Carbapenem‐resistant bacteria are …
treat infections caused by antibiotic‐resistant bacteria. Carbapenem‐resistant bacteria are …
Неблагоприятные тенденции в этиологии ортопедической инфекции: результаты 6-летнего мониторинга структуры и резистентности ведущих …
СА Божкова, АР Касимова, РМ Тихилов… - … и ортопедия России, 2018 - cyberleninka.ru
Остеомиелит до настоящего времени остается одним из самых трудноизлечимых
заболеваний. Характер возбудителя и его резистентность к антибиотикам значимо …
заболеваний. Характер возбудителя и его резистентность к антибиотикам значимо …
Identification of Acinetobacter baumannii and its carbapenem-resistant gene blaOXA-23-like by multiple cross displacement amplification combined with lateral …
S Hu, L Niu, F Zhao, L Yan, J Nong, C Wang, N Gao… - Scientific Reports, 2019 - nature.com
Acinetobacter baumannii is a frequent cause of the nosocomial infections. Herein, a novel
isothermal amplification technique, multiple cross displacement amplification (MCDA) is …
isothermal amplification technique, multiple cross displacement amplification (MCDA) is …
Double-and multi-carbapenemase-producers: the excessively armored bacilli of the current decade
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative nosocomial
pathogens commonly carry one carbapenemase gene conferring resistance to …
pathogens commonly carry one carbapenemase gene conferring resistance to …
VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey
Worldwide increase in carbapenem resistance and transferable carbapenemases are
significant challenges in treatment of Pseudomonas aeruginosa infections. In this study …
significant challenges in treatment of Pseudomonas aeruginosa infections. In this study …